Skip to main content
. 2019 Sep 27;10:1041. doi: 10.3389/fneur.2019.01041

Figure 9.

Figure 9

Mechanism of neuroprotection mediated by dexmedetomidine in astrocytes and MCAO rats. Dexmedetomidine (Dex) improved glutamate transporter-1 (GLT-1) expression by activating α2 adrenergic receptor through PI3K/Akt signaling pathway. Upregulation of GLT-1 enhanced the uptaken of extracellular glutamate (Glu) to protect neurons from excitotoxicity. The effect of dexmedetomidine improved the neurological deficit and reduced the infarct volume in MCAO model rats.